Evidence map›Paper›PMID 39173885›Full record

ReviewJournal of the American Academy of Dermatology2025

The skin microbiome in dermatologic disease.

Margaret A MacGibeny, Susuana Adjei, Hunter Pyle, Christopher G Bunick, Mahmoud Ghannoum, Ayman Grada, Tamia Harris-Tryon, Stephen K Tyring, Heidi H Kong

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of the American Academy of Dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Margaret A MacGibenyDepartment of Dermatology, Yale School of Medicine, New Haven, Connecticut.
Susuana AdjeiDepartment of Dermatology, Lake Granbury Medical Center, Dallas, Texas.
Hunter PyleDepartment of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.
Christopher G BunickDepartment of Dermatology, Yale School of Medicine, New Haven, Connecticut; Program in Translational Biomedicine, Yale School of Medicine, New Haven, Connecticut.
Mahmoud GhannoumIntegrated Microbiome Core and Center for Medical Mycology, Case Western Reserve University and University Hospitals Cleveland Medical Center, Cleveland, Ohio; Department of Dermatology, Case Western Reserve University and University Hospitals Cleveland Medical Center, Cleveland, Ohio.
Ayman GradaIntegrated Microbiome Core and Center for Medical Mycology, Case Western Reserve University and University Hospitals Cleveland Medical Center, Cleveland, Ohio.
Tamia Harris-TryonDepartment of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.
Stephen K TyringDepartment of Dermatology, Center for Clinical Studies, McGovern School of Medicine, University of Texas Health Science Center, Houston, Texas. Electronic address: styring@ccstexas.com.
Heidi H KongDermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland. Electronic address: konghe@mail.nih.gov.

Funding

Studies of human microbes and potential perturbationsZIAAR041219 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI KONG, HEIDI · 2022 to 2025
$4.3M
Investigation of the natural history and pathogenesis of skin diseasesZIAAR041218 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI KONG, HEIDI · 2022 to 2025
$745k
Intramural NIH HHS Z99 AR999999Intramural NIH HHS ZIA AR041219
6 · The paper itself

Abstract

In Part I of our CME, we reviewed the skin microbiome in healthy individuals. Part II reviews the evolving understanding of alterations in the skin microbiome in specific human diseases. We also discuss how the skin microbiome can change with environmental exposures and medications such as antibiotics, as well as ongoing research on microbiome-based interventions.

Indexed as

MicrobiotaSkinSkin DiseasesAnti-Bacterial AgentsHumansSkin MicrobiomeAnti-Bacterial Agentsantibioticsantimicrobial resistancefecal microbiota transplantationinflammatory skin diseasesmicrobiome-based therapeuticsprebioticsprobiotics

Identifiers

PMID39173885
PMCPMC11839956

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.